Irreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapy
Matthew B. Lipner(Segeberger Kliniken), Jen Jen Yeh(University of North Carolina at Chapel Hill)
Cited by 40
Related Papers
Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial
|Clinical Cancer Research|2017|635
A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal Adenocarcinoma
|PLoS Medicine|2010|251
Hexokinase 2 promotes tumor growth and metastasis by regulating lactate production in pancreatic cancer
|Oncotarget|2016|205
The Role of Abdominoperineal Resection as Surgical Therapy for Anorectal Melanoma
|Annals of Surgery|2006|183